These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 31602781)
1. Higher expression of SATB2 in hepatocellular carcinoma of African Americans determines more aggressive phenotypes than those of Caucasian Americans. Yu W; Roy SK; Ma Y; LaVeist TA; Shankar S; Srivastava RK J Cell Mol Med; 2019 Dec; 23(12):7999-8009. PubMed ID: 31602781 [TBL] [Abstract][Full Text] [Related]
2. Oncogenic Role of SATB2 In Vitro: Regulator of Pluripotency, Self-Renewal, and Epithelial-Mesenchymal Transition in Prostate Cancer. Yu W; Srivastava R; Srivastava S; Ma Y; Shankar S; Srivastava RK Cells; 2024 Jun; 13(11):. PubMed ID: 38891096 [TBL] [Abstract][Full Text] [Related]
3. Chronic alcohol exposure induces hepatocyte damage by inducing oxidative stress, SATB2 and stem cell-like characteristics, and activating lipogenesis. Yu W; Ma Y; Shrivastava SK; Srivastava RK; Shankar S J Cell Mol Med; 2022 Apr; 26(7):2119-2131. PubMed ID: 35152538 [TBL] [Abstract][Full Text] [Related]
4. microRNA-4270-5p inhibits cancer cell proliferation and metastasis in hepatocellular carcinoma by targeting SATB2. Wang Y; Li CF; Sun LB; Li YC Hum Cell; 2020 Oct; 33(4):1155-1164. PubMed ID: 32504285 [TBL] [Abstract][Full Text] [Related]
5. Role of SATB2 in human pancreatic cancer: Implications in transformation and a promising biomarker. Yu W; Ma Y; Shankar S; Srivastava RK Oncotarget; 2016 Sep; 7(36):57783-57797. PubMed ID: 27472393 [TBL] [Abstract][Full Text] [Related]
6. Evidence for embryonic stem-like signature and epithelial-mesenchymal transition features in the spheroid cells derived from lung adenocarcinoma. Roudi R; Madjd Z; Ebrahimi M; Najafi A; Korourian A; Shariftabrizi A; Samadikuchaksaraei A Tumour Biol; 2016 Sep; 37(9):11843-11859. PubMed ID: 27048287 [TBL] [Abstract][Full Text] [Related]
7. Silencing of long noncoding RNA HOXA11-AS inhibits the Wnt signaling pathway via the upregulation of HOXA11 and thereby inhibits the proliferation, invasion, and self-renewal of hepatocellular carcinoma stem cells. Guo JC; Yang YJ; Zheng JF; Zhang JQ; Guo M; Yang X; Jiang XL; Xiang L; Li Y; Ping H; Zhuo L Exp Mol Med; 2019 Nov; 51(11):1-20. PubMed ID: 31757938 [TBL] [Abstract][Full Text] [Related]
8. Clinical significance of PNO1 as a novel biomarker and therapeutic target of hepatocellular carcinoma. Roy SK; Srivastava S; McCance C; Shrivastava A; Morvant J; Shankar S; Srivastava RK J Cell Mol Med; 2024 May; 28(9):e18295. PubMed ID: 38722284 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related]
10. Secreted protein acidic and rich in cysteine promotes epithelial-mesenchymal transition of hepatocellular carcinoma cells and acquisition of cancerstem cell phenotypes. Jiang X; Liu F; Wang Y; Gao J J Gastroenterol Hepatol; 2019 Oct; 34(10):1860-1868. PubMed ID: 31041810 [TBL] [Abstract][Full Text] [Related]
11. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling. Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-598 inhibits the growth and maintenance of gastric cancer stem-like cells by down-regulating RRS1. Ma Y; Yan F; Wei W; Deng J; Li L; Liu L; Sun J Cell Cycle; 2019 Oct; 18(20):2757-2769. PubMed ID: 31438772 [TBL] [Abstract][Full Text] [Related]
13. miR-211 suppresses hepatocellular carcinoma by downregulating SATB2. Jiang G; Cui Y; Yu X; Wu Z; Ding G; Cao L Oncotarget; 2015 Apr; 6(11):9457-66. PubMed ID: 25888635 [TBL] [Abstract][Full Text] [Related]
14. Arsenite inhibits the function of CD133 Tang H; Jin Y; Jin S; Tan Z; Peng Z; Kuang Y Tumour Biol; 2016 Oct; 37(10):14103-14115. PubMed ID: 27517564 [TBL] [Abstract][Full Text] [Related]
15. BORIS up-regulates OCT4 via histone methylation to promote cancer stem cell-like properties in human liver cancer cells. Liu Q; Chen K; Liu Z; Huang Y; Zhao R; Wei L; Yu X; He J; Liu J; Qi J; Qin Y; Li B Cancer Lett; 2017 Sep; 403():165-174. PubMed ID: 28645561 [TBL] [Abstract][Full Text] [Related]
16. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma. Modi SJ; Kulkarni VM Eur J Med Chem; 2020 Dec; 207():112851. PubMed ID: 33002846 [TBL] [Abstract][Full Text] [Related]
17. miR-34a Inhibits Cell Proliferation by Targeting SATB2 in Hepatocellular Carcinoma. Wu G; Li Z; Wang Y; Ju X; Huang R Biomed Res Int; 2018; 2018():2863902. PubMed ID: 30627547 [TBL] [Abstract][Full Text] [Related]
18. Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. Bourguignon LY; Wong G; Earle C; Chen L J Biol Chem; 2012 Sep; 287(39):32800-24. PubMed ID: 22847005 [TBL] [Abstract][Full Text] [Related]
19. Cellular transformation of human mammary epithelial cells by SATB2. Yu W; Ma Y; Ochoa AC; Shankar S; Srivastava RK Stem Cell Res; 2017 Mar; 19():139-147. PubMed ID: 28167342 [TBL] [Abstract][Full Text] [Related]
20. A Novel Function for KLF4 in Modulating the De-differentiation of EpCAM Karagonlar ZF; Akbari S; Karabicici M; Sahin E; Avci ST; Ersoy N; Ates KE; Balli T; Karacicek B; Kaplan KN; Celiker C; Atabey N; Erdal E Cells; 2020 May; 9(5):. PubMed ID: 32408542 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]